118 related articles for article (PubMed ID: 28591280)
1. Keratoconus progression is not inhibited by reducing eyelid muscular force with botulinum toxin A treatment: a randomized trial.
Renesto ADC; Osaki TH; Osaki MH; Hirai FE; Campos M
Arq Bras Oftalmol; 2017; 80(2):88-92. PubMed ID: 28591280
[TBL] [Abstract][Full Text] [Related]
2. Refractive and visual outcomes after Ferrara corneal ring segment implantation at a 60% depth in keratoconic eyes: case series.
Renesto ADC; Hirai FE; Campos M
Arq Bras Oftalmol; 2019; 82(6):488-494. PubMed ID: 31482969
[TBL] [Abstract][Full Text] [Related]
3. Sequential topical riboflavin with or without ultraviolet a radiation with delayed intracorneal ring segment insertion for keratoconus.
Renesto Ada C; Melo LA; Sartori Mde F; Campos M
Am J Ophthalmol; 2012 May; 153(5):982-993.e3. PubMed ID: 22265143
[TBL] [Abstract][Full Text] [Related]
4. Influence of involuntary eyelid spasms on corneal topographic and eyelid morphometric changes in patients with hemifacial spasm.
Osaki T; Osaki MH; Osaki TH; Hirai FE; Nallasamy N; Campos M
Br J Ophthalmol; 2016 Jul; 100(7):963-970. PubMed ID: 26541432
[TBL] [Abstract][Full Text] [Related]
5. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
Vargel I; Canter HI; Topaloglu H; Erk Y
J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
[TBL] [Abstract][Full Text] [Related]
6. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking.
Vinciguerra P; Albè E; Trazza S; Rosetta P; Vinciguerra R; Seiler T; Epstein D
Ophthalmology; 2009 Mar; 116(3):369-78. PubMed ID: 19167087
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Refractive and Topographic Changes in Early and Advanced Keratoconic Eyes Undergoing Corneal Collagen Crosslinking.
Arora R; Jain P; Goyal JL; Gupta D
Cornea; 2013 Oct; 32(10):1359-64. PubMed ID: 23974893
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results.
Wittig-Silva C; Chan E; Islam FM; Wu T; Whiting M; Snibson GR
Ophthalmology; 2014 Apr; 121(4):812-21. PubMed ID: 24393351
[TBL] [Abstract][Full Text] [Related]
9. Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus.
Vinciguerra P; Albé E; Frueh BE; Trazza S; Epstein D
Am J Ophthalmol; 2012 Sep; 154(3):520-6. PubMed ID: 22633357
[TBL] [Abstract][Full Text] [Related]
10. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study.
Flynn TC; Carruthers JA; Carruthers JA; Clark RE
Dermatol Surg; 2003 Sep; 29(9):943-50; discussion 950-1. PubMed ID: 12930337
[TBL] [Abstract][Full Text] [Related]
11. Differences in Corneal Parameters Between Affected and Normal Contralateral Eyes in Patients With Hemifacial Spasm Treated With Botulinum Toxin-A: Outcomes During One Complete Treatment Cycle.
Osaki T; Osaki MH; Osaki TH; Hirai FE; Campos M
Cornea; 2016 Feb; 35(2):220-5. PubMed ID: 26619386
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative and postoperative effects of corneal collagen cross-linking on progressive keratoconus.
Vinciguerra P; Albè E; Trazza S; Seiler T; Epstein D
Arch Ophthalmol; 2009 Oct; 127(10):1258-65. PubMed ID: 19822840
[TBL] [Abstract][Full Text] [Related]
13. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
Bayraktar Bilen N; Bilen Ş; Topçu Yılmaz P; Evren Kemer Ö
Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
[TBL] [Abstract][Full Text] [Related]
14. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
[TBL] [Abstract][Full Text] [Related]
15. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
Colakoglu BD; Cakmur R; Uzunel F
Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
[TBL] [Abstract][Full Text] [Related]
16. United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment.
Hersh PS; Stulting RD; Muller D; Durrie DS; Rajpal RK;
Ophthalmology; 2017 Sep; 124(9):1259-1270. PubMed ID: 28495149
[TBL] [Abstract][Full Text] [Related]
17. Effects of corneal cross-linking on contrast sensitivity, visual acuity, and corneal topography in patients with keratoconus.
Lamy R; Netto CF; Reis RG; Procopio B; Porco TC; Stewart JM; Dantas AM; Moraes HV
Cornea; 2013 May; 32(5):591-6. PubMed ID: 23023410
[TBL] [Abstract][Full Text] [Related]
18. Effect of the eyelid speculum on pachymetry during corneal collagen crosslinking in keratoconus patients.
Soeters N; van Bussel E; van der Valk R; Van der Lelij A; Tahzib NG
J Cataract Refract Surg; 2014 Apr; 40(4):575-81. PubMed ID: 24568723
[TBL] [Abstract][Full Text] [Related]
19. Photorefractive keratectomy followed by cross-linking versus cross-linking alone for management of progressive keratoconus: two-year follow-up.
Alessio G; L'abbate M; Sborgia C; La Tegola MG
Am J Ophthalmol; 2013 Jan; 155(1):54-65.e1. PubMed ID: 23022158
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study.
Caporossi A; Mazzotta C; Baiocchi S; Caporossi T
Am J Ophthalmol; 2010 Apr; 149(4):585-93. PubMed ID: 20138607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
